Pulse Biosciences, Inc. (PLSE) Shareholder/Analyst Name April 25, 2026 1:45 PM EDT
Firm Members
Paul LaViolette – President, CEO & Co-Chairman of the Board
Robert Duggan
Darrin Uecker – CTO & Director
David Kenigsberg – Chief Medical Officer
Liane Teplitsky – Chief Working Officer
Convention Name Members
Anthony Petrone – Mizuho Securities USA LLC, Analysis Division
Joshua Jennings – TD Cowen, Analysis Division
Presentation
Paul LaViolette
President, CEO & Co-Chairman of the Board
Good afternoon, everyone. I am Paul LaViolette, Chief Government Officer of Pulse Biosciences. Actually proud to have this gathering at HRS. We have been making an attempt to supply updates at each single important assembly on the itinerary symposium. And right now represents a very nice alternative for us to see you once more.
Earlier than we dive in, I simply need to introduce just a few of the Pulse members who is not going to be presenting right now. I will be joined by Dr. Kenigsberg and Darrin Uecker, momentarily, our Chief Medical Officer, Chief Know-how Officer, respectively. I need to introduce Bob Duggan. Bob is our Chairman, our principal investor and actually the visionary for the final decade behind the institution of nsPFA as a next-generation vitality to ablate in EP and lots of different elements of the physique, as you are conscious.
Robert Duggan
And I will defer to Darrin Uecker at all times.
Paul LaViolette
President, CEO & Co-Chairman of the Board
Darrin is our Bob whisperer. I additionally need to introduce Liane Teplitsky. There she is, Liane. Liane has simply joined us as Chief Working Officer. Liane has a pronounced profession in med tech, however emphatically 18 or so years within the EP area. Is aware of a lot of our clinicians, is aware of the AFib know-how space intimately. We’re tremendous pleased to have her be a part of and so as to add some additional horsepower within the drive of our medical, regulatory and industrial areas.
Additionally becoming a member of Jon Skinner, our
